Trial Profile
Effectiveness and Tolerability of Tarka in the Treatment of Hypertensive Patients With High Risk of Developing Diabetes Mellitus, Not Controlled on Single-drug Therapy: A Multicountry, Multicenter, Post-marketing Observational Study in the Routine Clinical Use.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Dec 2012
Price :
$35
*
At a glance
- Drugs Verapamil/trandolapril (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Acronyms TARDIA
- Sponsors Abbott Laboratories
- 21 Apr 2010 New trial record